Keywords: hmr, rifapentine, approved, tb, says, panel, food
HMR's Rifapentine Should Be Approved For TB, Says Panel
Article | 07 May 1998
The US Food and Drug Administration's Antiviral Drugs AdvisoryCommittee has voted 10-to-1 to recommend approval of Hoechst Marion Roussel's Priftin ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
